Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
For patent explorations of some brand products
— Pharma advertising, Russia
To find examples of compounds losing patent protection in 2016-2019
— Researcher, Poland
For patent and exclusivity due dligience
— Pharma investment firm, USA
To search for the patent status of products that i will develop
— Business development executive, Indonesia
To get the patent status of key drugs
— Marketing manager, Chile
Generated: May 26, 2017
Which drugs does patent 8,747,896 protect, and when does it expire?
| Title: | Mucosal bioadhesive slow release carrier for delivering active principles |
| Abstract: | A mucosal bioadhesive slow release carrier comprising an active principle and devoid of starch, lactose, which can release the active principal for a duration of longer than 20 hours. This bioadhesive carrier contains a diluent, an alkali metal alkylsulfate, a binding agent, at least one bioadhesive polymer and at least one sustained release polymer, as well as a method for its preparation. |
| Inventor(s): | Costantini; Dominique (Paris, FR), Lemarchand; Caroline (Paris, FR) |
| Assignee: | BioAlliance Pharma (Paris, FR) |
| Application Number: | 13/565,653 |
|
Patent Claim Types: see list of patent claims | Formulation; Delivery; Use; |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cipher Pharms Us | SITAVIG | acyclovir | TABLET;BUCCAL | 203791-001 | Apr 12, 2013 | RX | Yes | Yes | 8,747,896 | ► Subscribe | Y | TREATMENT OF HERPES LABIALIS | |||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| 06290480 | Mar 24, 2006 | |
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8,211,466 | Mucosal bioadhesive slow release carrier for delivering active principles | ► Subscribe | |||||||||||||||||||||||||||
| 8,791,127 | Mucosal bioadhesive slow release carrier for delivering active principles | ► Subscribe | |||||||||||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.
| Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Russian Federation | 2420267 | ► Subscribe | |||||||||||||||||||||||||||
| Russian Federation | 2008139869 | ► Subscribe | |||||||||||||||||||||||||||
| Serbia | 51342 | ► Subscribe | |||||||||||||||||||||||||||
| Portugal | 1998750 | ► Subscribe | |||||||||||||||||||||||||||
| New Zealand | 571156 | ► Subscribe | |||||||||||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws,
it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.
To get patent expiration dates and find out when generics plan to advertise and enter the market
— Pharmacist, USA
For access to patents for competitive analysis and project managment
— Pharmaceutical industry consultant, USA
To get information on brands we work on currently or could potentially work on
— Marketing professional, USA
To watch the expiration date of patents on some of the drugs we work with
— Pharmaceutical researcher, Russia
To identify business opportunities and check patent rights
— Managing director pharmaceutical company, Morocco
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639
Follow DrugPatentWatch:
